Corient Private Wealth LP Cuts Holdings in Lam Research Corporation $LRCX

Corient Private Wealth LP lessened its stake in Lam Research Corporation (NASDAQ:LRCX) by 4.3% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,058,347 shares of the semiconductor company’s stock after selling 47,550 shares during the quarter. Corient Private Wealth LP owned 0.08% of Lam Research worth $458,340,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in Lam Research in the fourth quarter valued at approximately $3,645,427,000. Price T Rowe Associates Inc. MD lifted its stake in Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock worth $2,344,347,000 after acquiring an additional 10,666,540 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Lam Research during the 2nd quarter worth approximately $3,777,585,000. Franklin Resources Inc. grew its holdings in Lam Research by 57.0% during the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after acquiring an additional 3,671,073 shares in the last quarter. Finally, Corient Private Wealth LLC increased its position in shares of Lam Research by 235.5% in the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after purchasing an additional 3,649,553 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Stock Down 0.6%

Shares of NASDAQ:LRCX opened at $312.88 on Thursday. The firm has a 50 day simple moving average of $333.58 and a 200-day simple moving average of $288.43. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $391.51 billion, a PE ratio of 54.32, a P/E/G ratio of 1.25 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The firm had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period last year, the firm posted $1.33 EPS. The company’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

Insiders Place Their Bets

In other Lam Research news, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the sale, the director owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 80,441 shares of company stock valued at $27,614,296. 0.31% of the stock is currently owned by insiders.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-focused R&D expansion: Lam Research broke ground on a 120,000-square-foot laboratory in Tualatin, Oregon, as part of a planned investment of more than $3 billion in its global lab network over the next five years. The facility is intended to support collaboration with chipmakers and accelerate equipment innovations for advanced AI semiconductors. Lam Research Oregon lab announcement
• Positive Sentiment: Strong AI demand outlook: CEO Tim Archer said increasingly complex AI models require more computing power, bandwidth and storage, creating demand for semiconductor innovation. The investment reinforces Lam’s positioning as a supplier to the AI infrastructure buildout. Lam Research AI investment video
• Positive Sentiment: Favorable analyst and fundamentals commentary: Zacks highlighted AI-driven growth, recurring services revenue, earnings momentum and Lam’s balance sheet, while Mizuho maintained an “outperform” rating despite trimming its price target to $365 from $370. Lam’s latest reported quarter also showed 30% year-over-year revenue growth and an earnings beat.
• Neutral Sentiment: Investor outreach scheduled: CFO Doug Bettinger will participate in upcoming investor conferences. The events could provide updates on demand, AI exposure and the Oregon investment, but no new financial guidance was announced. Lam Research conference announcement
• Negative Sentiment: Investment and valuation concerns: The multibillion-dollar R&D expansion will raise near-term capital and operating costs, while the stock’s high earnings multiple leaves less room for disappointment. The modest analyst price-target reduction may also have limited enthusiasm.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on LRCX. Cantor Fitzgerald set a $500.00 price objective on shares of Lam Research and gave the company an “overweight” rating in a report on Monday, June 29th. TD Cowen reiterated a “buy” rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. B. Riley Financial cut their price target on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Finally, Barclays reaffirmed an “overweight” rating and set a $335.00 price target (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $357.31.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.